A protein involved with cell death can be manipulated to slow or reverse tumor growth, a pair of new studies in mice found.

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first ...

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first ...

Nucleome is backed by a world-class syndicate of investors: M Ventures, the venture capital arm of Merck KGaA; Johnson and Johnson Innovation - JJDC, Inc. ("JJDC"); Pfizer Ventures; British Business ...

Working with the same tumor slices that pathologists use to diagnose and guide treatment of patients, however, Carstens can ...

Technology opens the door to more accurate preclinical testing, which could enable the development of safer and more effective therapies.

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...

Arabidopsis thaliana was always an unlikely candidate for the limelight. But 25 years ago, the diminutive thale cress ...

Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and ...

Study reshapes view of how a common leukemia begins and could point to new therapeutic strategies targeting a common weakness.

Venezuela has an arsenal of Russian weapons and armed civilian cells that could mount a guerrilla war. But a coup against ...